Literature DB >> 28745698

[Telmisartan in the treatment of hypertensive patients].

V I Podzolkov1, A I Tarzimanova1.   

Abstract

The paper highlights the use of telmisartan, one of the currently available angiotensin receptor blockers, for the treatment of patients with hypertension, metabolic syndrome, and those at high cardiovascular risk. Telmisartan treatment allows blood pressure control, provides organ protection at different stages of the cardiovascular continuum, and reduces the risk of cardiovascular diseases and death. The additional properties and pleiotropic activity of the drug determines its wide range of applications in cardiology.

Entities:  

Keywords:  angiotensin receptor blockers; hypertension; telmisartan

Mesh:

Substances:

Year:  2017        PMID: 28745698     DOI: 10.17116/terarkh2017896110-113

Source DB:  PubMed          Journal:  Ter Arkh        ISSN: 0040-3660            Impact factor:   0.467


  2 in total

1.  Telmisartan Mitigates TNF-α-Induced Type II Collagen Reduction by Upregulating SOX-9.

Authors:  Xiuying Zhang; Yanfeng Dong; Hanyu Dong; Yanhui Cui; Qing Du; Xiaoli Wang; Lanlan Li; Hongju Zhang
Journal:  ACS Omega       Date:  2021-04-22

2.  Telmisartan mitigates lipopolysaccharide (LPS)-induced production of mucin 5AC (MUC5AC) through increasing suppressor of cytokine signaling 1 (SOCS1).

Authors:  Ling Chen; Jiajia Xu; Meiyu Deng; Yanling Liang; Jinfu Ma; Linghui Zhang; Yijie Wang; Jinping Zhang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.